All Articles

Lipocine's stock plummets after its PPD drug fails a Phase 3 trial, but a promising signal in a patient subset offers a narrow path forward.

The classic internet speed test is obsolete. A new standard, TR-471, is shifting focus to what matters: latency, jitter, and reliability under load.

As the U.S. nears its 250th, a new study shows Americans want brands, not politicians, to bridge divides. But authenticity is non-negotiable.

As chronic disease costs soar, a new program from Health Coach Institute promises to professionalize wellness coaching with structured, systems-based training.

With FDA clearance for clinical trials, CanWell Pharma’s novel CAN016 ADC brings a two-pronged attack against drug-resistant HER2-positive cancers.

As IDEX Corp prepares its Q1 2026 report, investors watch to see if strength in its tech segment can offset mixed industrial market signals.

With NASA's Artemis II circling the Moon, a coalition urges Congress to designate July 20 as a national day to honor Apollo's legacy and inspire explorers.

Newcomer Freedom Premium Finance partners with Input 1, leveraging a proven platform and regulatory support to enter the booming commercial premium finance market.

Global commodities giant Traxys finalizes its acquisition of Sweden's Carbomax, a move set to reshape the Nordic green steel market and bolster supply chains.

The full commercial launch of the Aeros Modular Stem System brings advanced 3D printing and a novel surgical approach to the competitive ankle replacement market.

The federal government extends crucial excise tax relief for small brewers, but with rising costs and declining sales, the industry says a bigger fix is needed.

OLX Group's new AI assistant uses proprietary market data to transform car shopping, promising a faster, smarter, and more personal vehicle search.

A new 'agentic' AI platform promises to revolutionize customs by giving governments real-time adaptability against sophisticated illicit trade networks.

JumpModel and Gogh Solutions merge, backed by Superstep Capital, to create a dominant, full-lifecycle IFS services platform for North American enterprises.

A new fintech partnership aims to provide personal loans to a vast, underserved market of Canadians with thin or non-existent credit histories.

Sabio Holdings is merging the booming creator economy with sports, launching a new venture that could disrupt how we watch and monetize competition.

AvenCell has dosed the first patient with AVC-203, a novel allogeneic CAR-T therapy, aiming to make advanced cancer treatment more accessible and effective.

A new $3M grant program targets the immune system's role in neurodegeneration, funding bold new research to combat Alzheimer's and Parkinson's.

Scientists propose a unifying model combining 'viral mimicry' and 'cancer dark matter,' potentially revolutionizing how our immune system recognizes and fights tumors.

LALIGA becomes the first European league to partner with a prediction market in North America, a bold move into a legally complex, high-stakes world.